No biomarker	Cervical Cancer	No biomarker	Cervical Cancer	AGEN2034 + UGN-301 Sensitive: B - Late Trials AGEN2034 + UGN-301 Sensitive : B	AGEN2034 + UGN-301 Sensitive: B - Late Trials AGEN2034 + UGN-301 Sensitive : B
No biomarker	Colorectal Cancer	No biomarker	Colorectal Cancer	AGEN2034 + AGEN1181 Sensitive: B - Late Trials AGEN2034 + AGEN1181 Sensitive : B	AGEN2034 + AGEN1181 Sensitive: B - Late Trials AGEN2034 + AGEN1181 Sensitive : B
PD-L1 expression	Cervical Cancer	PD-L1 expression	Cervical Cancer	AGEN2034 + UGN-301 Sensitive: C3 – Early Trials AGEN2034 + UGN-301 Sensitive : C3	AGEN2034 + UGN-301 Sensitive: C3 – Early Trials AGEN2034 + UGN-301 Sensitive : C3
PD-L1 expression	Colorectal Cancer	PD-L1 expression	Colorectal Cancer	AGEN2034 + AGEN1181 Sensitive: C3 – Early Trials AGEN2034 + AGEN1181 Sensitive : C3	AGEN2034 + AGEN1181 Sensitive: C3 – Early Trials AGEN2034 + AGEN1181 Sensitive : C3
NRAS mutation	Colorectal Cancer	NRAS mutation	Colorectal Cancer	AGEN2034 + AGEN1181 Sensitive: C3 – Early Trials AGEN2034 + AGEN1181 Sensitive : C3	AGEN2034 + AGEN1181 Sensitive: C3 – Early Trials AGEN2034 + AGEN1181 Sensitive : C3
KRAS mutation	Colorectal Cancer	KRAS mutation	Colorectal Cancer	AGEN2034 + AGEN1181 Sensitive: C3 – Early Trials AGEN2034 + AGEN1181 Sensitive : C3	AGEN2034 + AGEN1181 Sensitive: C3 – Early Trials AGEN2034 + AGEN1181 Sensitive : C3

CTLA4 antagonist

Associations(6)